Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Angle Share News (AGL)
AGL Share
Price
AGL Share
News
AGL Share
Chat
AGL Share
Trades37
AGL
Live RNS
AGL Share
Charts
AGL Broker
Ratings
AGL Directors
Deals
AGL Financial
Diary
AGL
Fundamentals
AGL Short
Positions
AGL
Media
AGL Company
Research
AGL Company
Timeline
- There is currently no data for AGL
IN BRIEF: Angle highlights supportive data for DNA analysis tool
Angle PLC - Surrey-based medical diagnostics provider - Announces publication of a peer-reviewed paper in a special issue of the journal - "Current Issues in Molecular Biology" Special Issue: Advanced Solutions for Cancer Therapy. Article brings together supporting evidence for the additional and complementary information that can be obtained from circulating tumour cells, demonstrating the value of a dual analyte approach for both CTCs and ctDNA (fragments of DNA released mainly by dying cells). Angle recently announced breakthrough data for real-time parallel next generation sequencing DNA analysis of both ctDNA and CTCs from a single tube of patient blood, using a pan-cancer panel run on an Illumina NGS system.
Current stock price: 17.85 pence, down 8.5% in London on Monday
12-month change: down 42%
By Jeremy Cutler, Alliance News reporter
Comments and questions to newsroom@alliancenews.com
Copyright 2024 Alliance News Ltd. All Rights Reserved.
Latest AGL News
- ANGLE Sees Positive Evaluation Of Parsortix System
22 Jul 2014 - ANGLE Seeks To Strengthen Parsortix IP With Further Applications
8 Apr 2014 - ANGLE Applies For In Vitro Approval For Parsortix In US
17 Mar 2014 - Angle Shares Up On Positive Test Results Using Parsortix
24 Feb 2014 - UK MIDDAY BRIEFING: Inflation Below Target For First Time In 4 Years
18 Feb 2014 - UK WINNERS & LOSERS: Randgold, Goldstone Fall As Drilling Results Disappoint
18 Feb 2014 - ANGLE To Launch Parsortix At Berlin Medical Conference Wednesday
18 Feb 2014 - ANGLE Focused On Market Adoption For Parsortix As Loss Widens
30 Jan 2014
Related News
IN BRIEF: Angle names Peter Collins as interim CEO
(Alliance News) - Angle PLC - Guildford, England-based liquid biopsy company, which is to be renamed CelLBxHealth PLC - Appoints Peter Collins as inte...
Angle touts planned name and strategy change, Groen turns executive
(Alliance News) - Angle PLC shares fell on Wednesday, after it announced plans to rename itself CelLBxHealth PLC and "[pursue] a revised strategy", wi...
IN BRIEF: Angle CEO and finance lead step down after shareholder talks
Angle PLC - Guildford, England-based liquid biopsy company - Says that, following talks with an unnamed "significant shareholder", Chief Executive Off...
Angle News
ANGLE Seeks To Strengthen Parsortix IP With Further Applications
LONDON (Alliance News) - Specialist medical technology company ANGLE PLC said Tuesday that it has taken steps to strengthen its intellectual property ...
ANGLE Applies For In Vitro Approval For Parsortix In US
LONDON (Alliance News) - ANGLE PLC said Monday it has made a submission to the United States Food and Drug Administration for the authorisation of the...
Angle Shares Up On Positive Test Results Using Parsortix
LONDON (Alliance News) - Shares in ANGLE PLC rose 6.7% Monday after it saw positive results using its Parsortix system to analyse Circulating Tumour C...
UK MIDDAY BRIEFING: Inflation Below Target For First Time In 4 Years
LONDON (Alliance News) - The UK's inflation rate has fallen below the Bank of England's 2% target for the first time in more than four years Tuesday, ...
UK WINNERS & LOSERS: Randgold, Goldstone Fall As Drilling Results Disappoint
LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Tuesday. ------- FTSE 100 - WIN...
ANGLE To Launch Parsortix At Berlin Medical Conference Wednesday
LONDON (Alliance News) - Shares in ANGLE PLC were on the rise Tuesday morning, after the specialist med-tech company said it will launch its Parsortix...
ANGLE Focused On Market Adoption For Parsortix As Loss Widens
LONDON (Alliance News) - ANGLE PLC said Thursday that it was focused on establishing widespread market adoption for its Parsortix cell separation syst...
Follow the stocks
